Impaired Glymphatic System Actions in Obstructive Sleep Apnea Adults

Study ObjectivesObstructive sleep apnea (OSA) is accompanied by sleep fragmentation and altered sleep architecture, which can potentially hinder the glymphatic system, increasing risks for Alzheimer's disease (AD), but the status is unclear in OSA. Our aim was to investigate the glymphatic system in OSA subjects and examine the relationships between OSA disease severity, sleep symptoms, and glymphatic system indices in OSA using diffusion tensor imaging (DTI). MethodsWe acquired DTI data from 59 OSA and 62 controls using a 3.0-Tesla MRI and examined OSA disease severity and sleep symptoms with the Pittsburgh Sleep Quality Index (PSQI) and Epworth Sleepiness Scale (ESS). Diffusivity maps in the x-axis (D-xx), y-axis (D-yy), and z-axis (D-zz), as well as in x-y axis (D-xy), y-z axis (D-yz), and x-z axis (D-xz) were calculated, diffusion values for the projection and association fibers extracted, and the DTI analyses along the perivascular space (DTI-ALPS index) were performed. The glymphatic system indices were compared between groups and correlated with disease severity and sleep symptoms in OSA subjects. ResultsD(zz) values, derived from projection fiber areas, D-yy and D-zz values from association fiber areas, as well as ALPS and D-yzmean values were significantly reduced in OSA over controls. Significant correlations emerged between disease severity, sleep symptoms, and D-xy, D-xx, and D-zz values in OSA subjects. ConclusionOSA patients show abnormal glymphatic system function that may contribute to increased risks for AD. The findings suggest that the APLS method can be used to assess the glymphatic system in OSA patients.

Automated summary

The study investigates the glymphatic system in subjects with obstructive sleep apnea (OSA) using diffusion tensor imaging (DTI). The results reveal abnormal glymphatic system function in OSA patients, which may contribute to increased risks for Alzheimer's disease (AD). The study suggests that the APLS method can be used to assess the glymphatic system in OSA patients.